1. Lilly and BI tout new kidney disease data for Jardiance — Insulin providers prep for Brexit fallout — IGM updates its IPO, may raise over $200M — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Will anyone from Rheumatology be retained?

Discussion in 'Celgene' started by anonymous, Apr 18, 2019 at 7:23 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    in a rheumatology position? If so, will I simply be a layover rep for some existing BMS reps who sell Orencia 1st and I come along and clean up with Otezla?

    I understand that dermatology is fine and I get that, but I'd really rather stay with my existing customers in rheumatology but if I am only going to be a layover I'd rather go on over to MS, even if the drug is #25 in crowded market with no differentiation.
     
  2. anonymous

    anonymous Guest

    No one knows. Why even bother asking?
     
  3. anonymous

    anonymous Guest

    It won’t be your choice to move over to MS. Those spots will be for very high ranked reps and preferably reps with MS experience. Not to mention Celgene won’t be in charge of hiring the ozanimod reps, BMS will.
     
  4. anonymous

    anonymous Guest

    Time to move on.
     
  5. anonymous

    anonymous Guest

    Exactly, I also don’t get all the OZ promotions to marketing and regional positions. Won’t BMS want to pick those?
     
  6. anonymous

    anonymous Guest

    Who says Derm is fine? Just because BMS doesn’t have a derm division doesn’t mean all the derm reps are okay. They could end up combining territories, making hybrid reps, completely hire from within. We have no idea what’s going to happen. Just gotta wait it out. Whatever happens though don’t worry. The severance is amazing either way.
     
  7. anonymous

    anonymous Guest


    sorry, no.

    BMS want the product to get approve and hum. period. For that to happened, things really need to happen on the back end between the end of March 19 and about November this year. After that, it's just adjustments. BMS can't wait until the deal closes, then wait more for DayOne, then more for integration or the game is already over.
     
  8. anonymous

    anonymous Guest

    What the hell are you talking about? Your writing and grammar are not understandable!
     
  9. anonymous

    anonymous Guest

    Sorry, no drinking during work hours
     
  10. anonymous

    anonymous Guest


    This is definitely one of the recent promotions or English isn’t the primary language.
     
  11. anonymous

    anonymous Guest

    Yes, 24 of you.
     
  12. anonymous

    anonymous Guest

    From an employee law perspective it’s easier for BMS to let us all go. BMS will have territories drawn up and where they have a vacancy, we can interview. Many will land on our feet in derm/rheum because that division is small at BMS.